U.S. markets open in 8 hours 22 minutes
  • S&P Futures

    4,226.75
    +4.50 (+0.11%)
     
  • Dow Futures

    33,826.00
    +21.00 (+0.06%)
     
  • Nasdaq Futures

    14,199.25
    +33.75 (+0.24%)
     
  • Russell 2000 Futures

    2,286.00
    +1.50 (+0.07%)
     
  • Crude Oil

    70.59
    -0.45 (-0.63%)
     
  • Gold

    1,785.60
    +10.80 (+0.61%)
     
  • Silver

    26.25
    +0.39 (+1.52%)
     
  • EUR/USD

    1.1912
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.5110
    0.0000 (0.00%)
     
  • Vix

    17.75
    -0.40 (-2.20%)
     
  • GBP/USD

    1.3905
    -0.0019 (-0.14%)
     
  • USD/JPY

    110.1750
    -0.0560 (-0.05%)
     
  • BTC-USD

    37,858.70
    -870.95 (-2.25%)
     
  • CMC Crypto 200

    942.19
    -27.68 (-2.85%)
     
  • FTSE 100

    7,153.43
    -31.52 (-0.44%)
     
  • Nikkei 225

    29,014.33
    -4.00 (-0.01%)
     

Oramed working on first insulin pill for diabetes

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Oramed Pharmaceuticals is waiting on approval from the FDA after its new insulin pill to treat type two diabetes had successful results in its phase two trial. Oramed Pharmaceuticals CEO Nadav Kidron joins Yahoo Finance’s Brian Sozzi and Alexis Christoforous to discuss on The First Trade.